Results for this period
Full year1 April 2025 to 31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Decline in unit prices linked to purchase prices for LP gas, increase in rentals and sales of home healthcare equipment, increase in gross profit, increase in selling, general and administrative expenses, and increase in gains on sales of property, plant and equipment
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 March 2026 |
| Net Sales | ¥32,697 million (YoY -2.2%) |
| Operating profit | ¥1,300 million (YoY +2.7%) |
| Ordinary income | ¥1,401 million (YoY +3.2%) |
| Profit attributable to owners of the parent | ¥960 million (YoY +8.0%) |
| Net income per share | ¥125.17 |
| Operating Margin | 4 |
| Equity ratio | End of the current fiscal period 68.9 / End of previous period 67.4 |
| Total assets | ¥23,168 million |
| Net assets | ¥15,952 million |
| Cash flows from operating activities | ¥2,725 million |
| Cash flows from investing activities | ¥-2,272 million |
| Cash flows from financing activities | ¥-338 million |
| Cash and cash equivalents at end of period | ¥3,222 million |
| Full-year earnings forecast | Net Sales ¥33,500 million (YoY +2.5%) / Operating profit ¥1,400 million (YoY +7.7%) / Ordinary income ¥1,480 million (YoY +5.6%) / Net income ¥900 million (YoY -6.3%) |
| Annual Dividend Forecast | ¥27 → ¥29（+7.4%） |
| Payout ratio | Fiscal year ending March 2026 23.2 % / Forecast for the fiscal year ending March 2027 24.7 % |
| Segment revenue | Living business ¥22,479,880 thousand (YoY -6.5%), Aqua business ¥1,253,860 thousand (YoY +2.0%), Medical and Industrial Gases business ¥8,963,881 thousand (YoY +10.1%) |
| Segment profit | Living business ¥775,639 thousand (YoY +5.2%), Aqua business ¥51,406 thousand (YoY -17.3%), Medical and Industrial Gases business ¥473,021 thousand (YoY +1.3%) |
| Depreciation and amortization | ¥1,429,271 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥89,314 thousand, Gain on sale of investment securities ¥2,580 thousand / Extraordinary loss Loss on disposal and sale of non-current assets ¥18,339 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Event No / Subject person None |
| Issued Shares at Period-End | 8,046,500 |
| Treasury Shares at Period-End | 371,888 |
| Factors Behind Changes in Business Performance | Decline in unit prices linked to purchase prices for LP gas, increase in rentals and sales of home healthcare equipment, increase in gross profit, increase in selling, general and administrative expenses, and increase in gains on sales of property, plant and equipment |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue decreased because, despite increased rentals and sales of home healthcare equipment in the Medical and Industrial Gases business, unit prices in the Living business declined in line with lower purchase prices for LP gas, among other factors. Operating profit increased as gross profit rose by more than selling, general and administrative expenses. Net income attributable to owners of the parent increased due mainly to higher gains on sales of property, plant and equipment.